Drug Shortage Report for TEVA-ZOPICLONE

Last updated on 2021-06-03 History
Report ID 136350
Drug Identification Number 02246534
Brand name TEVA-ZOPICLONE
Common or Proper name ZOPICLONE 5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ZOPICLONE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-24
Estimated end date 2021-07-31
Actual end date 2021-06-02
Shortage status Resolved
Updated date 2021-06-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-03-25 English Compare
v2 2021-03-25 French Compare
v3 2021-04-08 English Compare
v4 2021-04-08 French Compare
v5 2021-04-21 English Compare
v6 2021-04-21 French Compare
v7 2021-04-29 English Compare
v8 2021-04-29 French Compare
v9 2021-06-03 English Compare
v10 2021-06-03 French Compare

Showing 1 to 10 of 10